The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis

Rheumatology (Oxford). 2015 Aug;54(8):1339-41. doi: 10.1093/rheumatology/kev196. Epub 2015 May 26.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cyclophosphamide / adverse effects*
  • Cyclophosphamide / therapeutic use*
  • Female
  • Granulomatosis with Polyangiitis / drug therapy*
  • Humans
  • Male
  • Skin Neoplasms / epidemiology*
  • Urinary Bladder Neoplasms / epidemiology*

Substances

  • Cyclophosphamide